Marijuana Inc. (MAJI)
Market Cap | 5.79M |
Revenue (ttm) | n/a |
Net Income (ttm) | -854.02K |
Shares Out | 35.09M |
EPS (ttm) | -0.06 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 14,100 |
Average Volume | 174,325 |
Open | 0.2000 |
Previous Close | 0.2000 |
Day's Range | 0.1600 - 0.2000 |
52-Week Range | 0.0050 - 0.3200 |
Beta | -3.94 |
RSI | 51.53 |
Earnings Date | n/a |
About Marijuana
Marijuana Inc. distributes cannabis products in the United States. The company was formerly known as GRN Holding Corporation and changed its name to Marijuana Inc. in October 2024. Marijuana Inc. was founded in 2010 and is based in Estero, Florida. [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews

Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview
A published paper shows NANOG Expression was almost 100% effective at eradicating tumor cells ORLANDO, FL / ACCESS Newswire / April 21, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a ...

Exousia Pro Offers Guidance on New Subdivisions
ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is p...

Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show
Exousia Pro has a 60% margin built-in on each order of exosomes ORLANDO, FLORIDA / ACCESS Newswire / April 8, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech comp...

Exousia Pro Issues Update on Name Change
ORLANDO, FLORIDA / ACCESS Newswire / April 3, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other dis...

Exousia Pro Has Appointed Matthew Dwyer As Its New President
ORLANDO, FL / ACCESS Newswire / April 2, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is...

Exousia Pro Issues and Update on its FDA Orphan Drug Status
ORLANDO, FL / ACCESS Newswire / April 1, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is...

Exousia Pro Officially Announces the Production of Plant-Based Exosomes Has Begun
Exousia Pro will be sending out samples to clients expected to place orders ORLANDO, FL / ACCESS Newswire / March 25, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., announces the offici...

Exousia Has Successfully Renegotiated Its License Agreement
ORLANDO, FL / ACCESS Newswire / March 18, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is...